The prospect of genomic, transcriptomic, epigenetic and metabolomic biomarkers for the personalized prevention of type 2 diabetes and cardiovascular diseases
A Zeljkovic, M Mihajlovic, S Vujcic… - Current Vascular …, 2023 - ingentaconnect.com
Cardiometabolic diseases, such as type 2 diabetes mellitus (DM) and cardiovascular
disease (CVD), are a great health concern. The strategies aimed to increase awareness and …
disease (CVD), are a great health concern. The strategies aimed to increase awareness and …
[引用][C] The Prospect of Genomic, Transcriptomic, Epigenetic and Metabolomic Biomarkers for The Personalized Prevention of Type 2 Diabetes and Cardiovascular …
A Zeljkovic, M Mihajlovic, S Vujcic… - Current Vascular …, 2023 - scindeks.ceon.rs
The Prospect of Genomic, Transcriptomic, Epigenetic and Metabolomic Biomarkers for The Personalized Prevention of Type 2 Diabetes and Cardiovascular Diseases
A Zeljkovic, M Mihajlovic, S Vujcic… - Current vascular …, 2023 - pubmed.ncbi.nlm.nih.gov
Cardiometabolic diseases, such as type 2 diabetes mellitus (DM) and cardiovascular
disease (CVD), are a great health concern. The strategies aimed to increase awareness and …
disease (CVD), are a great health concern. The strategies aimed to increase awareness and …
The prospect of genomic, transcriptomic, epigenetic and metabolomic biomarkers for the personalized prevention of type 2 diabetes and cardiovascular diseases.
A Zeljkovic, M Mihajlovic, S Vujcic… - Current Vascular …, 2023 - europepmc.org
Cardiometabolic diseases, such as type 2 diabetes mellitus (DM) and cardiovascular
disease (CVD), are a great health concern. The strategies aimed to increase awareness and …
disease (CVD), are a great health concern. The strategies aimed to increase awareness and …
[引用][C] The Prospect of Genomic, Transcriptomic, Epigenetic and Metabolomic Biomarkers for The Personalized Prevention of Type 2 Diabetes and Cardiovascular …
A Zeljkovic, M Mihajlovic, S Vujcic… - Current Vascular …, 2023 - scindeks.ceon.rs